glp-1 and dual glp-1/gip receptor agonists GIP/GLP-1 agonists: New advances for treating type-2 diabetes PDB-101: Molecule of the Month:
Description
References 1.Gerich JE
But their appeal doesnt stop there
Before PSM, significant differences were observed in various covariates
Furthermore, multiple additional meta-analyses have consistently shown no significant association between GLP-1RA therapy and pancreatic cancer risk
GLP-1 medications do not replace physical activity or healthy eating habits as a way to lose weight
[DOI] [PubMed] [Google Scholar] 9.Koliaki C., Doupis J
